We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Do you have Essential Thrombocythaemia (ET)?
- Are you 18 years old or over?
- Are you or have you in the past been resistant or intolerant to hydroxycarbamide(hydroxyurea) treatment?
Consider your options with the VECTRA study
Learn more about the study or to find out if the study could be right for you
About the study
- The study aims to evaluate the safety and effectiveness of dencatistat (STP938).
- You would be given capsule(s) of dencatistat to take once daily.
- Based on other studies, dencatistat may be a good option for patients with ET.
If you think the study might be right for you
- You will be asked to attend a screening visit at the clinic.
- During this visit you will be asked some questions about your general health.
- You will be asked to provide blood and urine samples as well as have some examinations to see if you are suitable to take part in this research study.
Published: Apr 23, 2026